Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: Impact of different mobilisation regimens

Bone Marrow Transplantation

Volumn 27, Issue 11, 2001, Pages 1125-1132

  Deininger, M ^a   Ponisch W ^a   Krahl, R ^a   Leiblein, S ^a   Edel, E ^a   Lange, T ^a   Fiedler, F ^a   Freund, M ^a   Franke, A ^a   Pasold, R ^a   von Grunhagen U ^a   Herold, M ^a   Dolken G ^a   Hoffmann, F A ^a   Uhle, R ^a   Schultze, W ^a   Steglich, J ^a   Schwarzer, A ^a   Richter, P ^a   Winkelmann, C ^a   Kettner, E ^a   Dachselt, K ^a   Subert R ^a   Schwalbe, E ^a   Doepper, J ^a   Helbig, ^a   more..

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Autografting; CML; Mobilisation chemotherapy; Stem cell mobilisation

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IDARUBICIN;

ADOLESCENT; ADULT; ADVANCED CANCER; ARTICLE; AUTOGRAFT; CANCER CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; COLONY FORMING UNIT GM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOGENETICS; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL; PHILADELPHIA 1 CHROMOSOME; PNEUMONIA; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; CYTARABINE; FEMALE; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; IDARUBICIN; INTERFERON-ALPHA; LEUKAPHERESIS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME;

EID: 0034954077     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703057     Document Type: Article

References (23)

1. Optimizing treatment for chronic myeloid leukemia
2. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia
3. Treatment of blastic transformation of chronic granulocytic leukemia by high dose cyclophosphamide, total body irradiation and infusion of cryopreserved autologous marrow
4. Autografting cryopreserved buffy coat cells for chronic granulocytic leukaemia in transformation
5. Autologous transplants for chronic myelogenous leukaemia: Results from eight transplant groups
6. Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia
7. Results of treatment of Ph′ + chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol)
8. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia
9. Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: Mobilization of Philadelphia-negative peripheral blood stem cells
10. Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia
11. Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied
12. Enhancement of banding patterns in human metaphase chromosomes by energy transfer
13. Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment
14. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: Comparison with cytogenetics and PCR from uncultured cells
15. Autologous transplantation therapy for chronic myelogenous leukemia
16. High-dose cyclophosphamide for mobilization of circulating stem cells in chronic myeloid leukemia
17. Autologous transplantation therapy for chronic myelogenous leukemia
18. Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide
19. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML
20. Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia
21. Effective mobilization of Philadelphia-chromosome-negative cells in chronic myelogenous leukaemia patients using a less intensive regimen
22. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia
23. Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML